Category In The News
An in-depth update from Medscape on the debate surrounding the use of Avastin in treating GBM. ABC2's petitioning of the FDA is noted.
An interview with biogeneticist Eric S. Lander in the January/February issue of The Atlantic.
Dr. Shawn Carbonell is OncoSynergy's CEO and his wife, Dr. Anne-Marie Carbonell, is the VP of Clinical Development. OncoSynergy is the Social Media Sponsor of the 2014 Race for Hope DC.
Recurrent Brain Cancers Follow Distinctive Genetic Paths, UCSF Team Shows Commonly Used Brain Tumor Chemotherapy Agent May Propel Recurrent Tumors to Malignancy
Enjoy discounted seats at the Miami HEAT game on January 21st and support brain cancer research.
The latest update on the UF pediatric research project funded by Accelerate Brain Cancer Cure, Paul Hale and the Florida Brain Tumor Association.
The proceeds of the charity tournament support Accelerate Brain Cancer Cure's collaborative research funding at University of Florida.
With the support of many friends, co-workers and family, our team has raised over $59,000 for brain tumor research.
The Phase II trial is led by Dr. Duane Mitchell, director of the UF Brain Tumor Immunotherapy Program.
Key industry and foundation leaders were invited to share their disruptive ideas on the future of neurosurgery at the new CNS Neurosurgery Innovations Symposium.